Patents by Inventor Teresa L. Born
Teresa L. Born has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8053233Abstract: A novel polypeptide that functions as an IL-18 receptor is disclosed. The receptor is multimeric and includes at least one AcPL polypeptide, or fragment thereof, and at least one IL-1Rrp1 polypeptide, or fraction thereof. The receptor binds IL-18 and finds use in inhibiting biological activities mediated by IL-18.Type: GrantFiled: March 3, 2010Date of Patent: November 8, 2011Assignee: Immunex CorporationInventors: John E. Sims, Teresa L. Born
-
Patent number: 7993845Abstract: The invention is directed to purified and isolated novel ACPL polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.Type: GrantFiled: October 12, 2010Date of Patent: August 9, 2011Assignee: Immunex CorporationInventors: John E. Sims, Teresa L. Born
-
Publication number: 20110027805Abstract: The invention is directed to purified and isolated novel ACPL polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.Type: ApplicationFiled: October 12, 2010Publication date: February 3, 2011Applicant: IMMUNEX CORPORATIONInventors: John E. SIMS, Teresa L. BORN
-
Patent number: 7838248Abstract: The invention is directed to purified and isolated novel ACPL polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.Type: GrantFiled: September 17, 2007Date of Patent: November 23, 2010Assignee: Immunex CorporationInventors: John E. Sims, Teresa L. Born
-
Publication number: 20100190211Abstract: A novel polypeptide that functions as an IL-18 receptor is disclosed. The receptor is multimeric and includes at least one AcPL polypeptide, or fragment thereof, and at least one IL-1Rrp1 polypeptide, or fraction thereof. The receptor binds IL-18 and finds use in inhibiting biological activities mediated by IL-18.Type: ApplicationFiled: March 3, 2010Publication date: July 29, 2010Applicant: IMMUNEX CORPORATIONInventors: John E. Sims, Teresa L. Born
-
Patent number: 7704945Abstract: A novel polypeptide that functions as an IL-18 receptor is disclosed. The receptor is multimeric and includes at least one AcPL polypeptide, or fragment thereof, and at least one IL-1Rrp1 polypeptide, or fraction thereof. The receptor binds IL-18 and finds use in inhibiting biological activities mediated by IL-18.Type: GrantFiled: January 29, 2007Date of Patent: April 27, 2010Assignee: Immunex CorporationInventors: John E. Sims, Teresa L. Born
-
Publication number: 20100047867Abstract: The invention is directed to novel, purified and isolated IL-1 zeta and Xrec2 polypeptides and fragments thereof, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and uses thereof.Type: ApplicationFiled: August 3, 2009Publication date: February 25, 2010Applicant: Immunex CorporationInventors: John E. Sims, Dirk E. Smith, Teresa L. Born
-
Publication number: 20090297517Abstract: The invention pertains to methods for treating medical disorders characterized by elevated levels or abnormal expression of IL-18 by administering an IL-18 antagonist, such as soluble IL-18 receptor, a soluble IL-18 binding protein and/or an antibody.Type: ApplicationFiled: August 3, 2009Publication date: December 3, 2009Applicant: IMMUNEX CORPORATIONInventors: John E. SIMS, Kendall M. MOHLER, Teresa L. BORN
-
Patent number: 7585949Abstract: The invention is directed to novel, purified and isolated IL-1 zeta and Xrec2 polypeptides and fragments thereof, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and uses thereof.Type: GrantFiled: March 13, 2007Date of Patent: September 8, 2009Assignee: Immunex CorporationInventors: John E. Sims, Dirk E. Smith, Teresa L. Born
-
Publication number: 20090004674Abstract: The invention is directed to purified and isolated novel ACPL polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.Type: ApplicationFiled: September 17, 2007Publication date: January 1, 2009Inventors: John E. Sims, Teresa L. Born
-
Publication number: 20080213257Abstract: The invention pertains to methods for treating medical disorders characterized by elevated levels or abnormal expression of IL-18 by administering an IL-18 antagonist, such as soluble IL-18 receptor, a soluble IL-18 binding protein and/or an antibody.Type: ApplicationFiled: February 28, 2007Publication date: September 4, 2008Applicant: Immunex CorporationInventors: John E. Sims, Kendal M. Mohler, Teresa L. Born
-
Patent number: 7270817Abstract: The invention is directed to purified and isolated novel ACPL polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.Type: GrantFiled: February 6, 2004Date of Patent: September 18, 2007Assignee: Immunex CorporationInventors: John E. Sims, Teresa L. Born
-
Patent number: 7217540Abstract: The invention is directed to novel, purified and isolated IL-1 zeta and Xrec2 polypeptides and fragments thereof, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and uses thereof.Type: GrantFiled: July 9, 2004Date of Patent: May 15, 2007Assignee: Immunex CorporationInventors: John E. Sims, Dirk E. Smith, Teresa L. Born
-
Patent number: 7169581Abstract: A novel polypeptide that functions as an IL-18 receptor is disclosed. The receptor is multimeric and includes at least one AcPL polypeptide, or fragment thereof, and at least one IL-1Rrp1 polypeptide, or fraction thereof. The receptor binds IL-18 and finds use in inhibiting biological activities mediated by IL-18.Type: GrantFiled: May 15, 2003Date of Patent: January 30, 2007Assignee: Immunex CorporationInventors: John E Sims, Teresa L Born
-
Patent number: 7033783Abstract: The invention is directed to novel, purified and isolated IL-1 zeta and Xrec2 polypeptides and fragments thereof, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and uses thereof.Type: GrantFiled: June 6, 2001Date of Patent: April 25, 2006Assignee: Immunex Corp.Inventors: John E. Sims, Dirk E. Smith, Teresa L. Born
-
Publication number: 20040248187Abstract: The invention is directed to novel, purified and isolated IL-1 zeta and Xrec2 polypeptides and fragments thereof, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and uses thereof.Type: ApplicationFiled: July 9, 2004Publication date: December 9, 2004Applicant: Immunex CorporationInventors: John E. Sims, Dirk E. Smith, Teresa L. Born
-
Publication number: 20040248254Abstract: The invention is directed to purified and isolated novel ACPL polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.Type: ApplicationFiled: December 15, 2003Publication date: December 9, 2004Applicant: Immunex CorporationInventors: John E. Sims, Teresa L. Born
-
Publication number: 20040138421Abstract: The invention is directed to purified and isolated novel ACPL polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.Type: ApplicationFiled: February 6, 2004Publication date: July 15, 2004Applicant: Immunex CorporationInventors: John E. Sims, Teresa L. Born
-
Patent number: 6692740Abstract: The invention is directed to purified and isolated novel ACPL polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.Type: GrantFiled: August 2, 2002Date of Patent: February 17, 2004Assignee: Immunex CorporationInventors: John E. Sims, Teresa L. Born
-
Patent number: 6693171Abstract: The invention is directed to purified and isolated novel ACPL polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.Type: GrantFiled: August 2, 2002Date of Patent: February 17, 2004Assignee: Immunex CorporationInventors: John E. Sims, Teresa L. Born
